Published in TB and Outbreaks Week, June 14th, 1999
This stalwart of the global campaign against TB may no longer work, and Stanford University researchers in California have discovered a possible reason why: the bacteria used to make the vaccine have jettisoned some of their genes. The discovery could guide the development of an up-to-date vaccine as well as a more accurate diagnostic test for the disease.
The TB vaccine, known as BCG, or bacille Calmette-Guerin, is one of the most widely used vaccines in the world. More than 1 billion people have received it, and an additional 100 million are vaccinated each year. "The vaccine is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week